Efficacy of lenvatinib combined with sintilimab and transcatheter arterial chemoembolization in conversion therapy for unresectable hepatocellular carcinoma
Jianwu Long, Jinli Zheng, Shiyi Chen, Peng Ou, Xianzhou Lu · 2026
Read Efficacy of lenvatinib combined with sintilimab and transcatheter arterial chemoembolization in conversion therapy for unresectable hepatocellular carcinoma by Jianwu Long, Jinli Zheng, Shiyi Chen, Peng Ou, Xianzhou Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624436.txt.
Description
Jianwu Long, Jinli Zheng, Shiyi Chen, Peng Ou, and Xianzhou Lu present a 2026 study of conversion therapy for liver cancer that cannot be removed at first. Conversion care aims to shrink a tumor until surgery becomes possible. The team compared a drug pair with a procedure that blocks the tumor's blood supply and delivers drugs through it.
They looked back at 153 patients treated at one hospital from 2023 to 2024. One group of 79 got the drug pair; 74 got the vessel procedure. The study compared response rates, tumor marker levels, tumor shape and blood flow, and side effects. The drug group showed a higher response rate, the authors report.
Catalog record
| CREATOR | Jianwu Long, Jinli Zheng, Shiyi Chen, Peng Ou, Xianzhou Lu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |